Literature DB >> 7689373

Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomologous monkeys.

H Ohzato1, M Monden, K Yoshizaki, M Gotoh, T Kanai, K Umeshita, T Tono, N Nishimoto, T Kishimoto, T Mori.   

Abstract

This study was designed to evaluate whether the sequential monitoring of serum interleukin-6 levels (SIL-6) could be helpful for diagnosing the occurrence of hepatic allograft rejection. An SIL-6 post-transplant study was conducted on nine cynomolgus monkeys which had undergone orthotopic hepatic allotransplantation, six of which were treated with FK-506 (a new immunosuppressant agent isolated from Streptomyces tsukubaensis) and three of which were not. All the nontreated animals showed biochemical abnormalities from days 5-6, characterized by a marked elevation of serum alkaline phosphatase levels, and they eventually died on days 8, 12, and 63 (group I). Acute cellular rejection was confirmed by histological study of the hepatic grafts taken at autopsy or biopsy. On the other hand, four of the treated animals (group IIa) survived more than 30 days. Biochemical examination of this group showed no abnormal signs apart from a slight elevation of alkaline phosphatase (< 2000 IU/l). Histological examination carried out around 30 days after transplantation revealed a transient infiltration of polynuclear cells into Glisson's area, with the portal vein and bile duct remaining intact. The remaining two animals (group IIb) died of dehydration and arterial thrombosis on days 5 and 7, respectively. A kinetic study of SIL-6 conducted during the first 2 weeks showed quite different patterns among the three groups. All recipients in group I demonstrated two peaks following grafting on days 1 and 3 or 4, the second peak of above 2.0 U/ml preceding biochemical abnormalities by 2 to 3 days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689373     DOI: 10.1007/bf00730628

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  31 in total

1.  Tolerance induction by liver grafting and FK 506 treatment in nonhuman primates.

Authors:  M Gotoh; M Monden; T Kanai; K Umeshita; K Wang; T Ukei; K Dono; T Tono; M Murata; J Tanimoto
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Multiple actions of interleukin 6 within a cytokine network.

Authors:  G G Wong; S C Clark
Journal:  Immunol Today       Date:  1988-05

3.  IL-1 stimulates IL-6 production in endothelial cells.

Authors:  M Sironi; F Breviario; P Proserpio; A Biondi; A Vecchi; J Van Damme; E Dejana; A Mantovani
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

Review 4.  Molecular regulation of B lymphocyte response.

Authors:  T Kishimoto; T Hirano
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection.

Authors:  D C Snover; R K Sibley; D K Freese; H L Sharp; J R Bloomer; J S Najarian; N L Ascher
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

6.  Role of T-cell-subset monitoring in renal-allograft recipients.

Authors:  P J Morris; N P Carter; P R Cullen; J F Thompson; R F Wood
Journal:  N Engl J Med       Date:  1982-05-06       Impact factor: 91.245

7.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

8.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

9.  Clinical significance of in situ detection of T lymphocyte subsets and monocyte/macrophage lineages in heart allografts.

Authors:  K Hoshinaga; T Mohanakumar; M H Goldman; T C Wolfgang; S Szentpetery; H M Lee; R R Lower
Journal:  Transplantation       Date:  1984-12       Impact factor: 4.939

10.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.

Authors:  C P Larsen; P J Morris; J M Austyn
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  2 in total

1.  Serum interleukin-6 and tumor necrosis factor-α are associated with early graft regeneration after living donor liver transplantation.

Authors:  Min Suk Chae; Kwang Uck Moon; Hyun Sik Chung; Chul Soo Park; Jaemin Lee; Jong Ho Choi; Sang Hyun Hong
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

Review 2.  IL-6 Directed Therapy in Transplantation.

Authors:  Cynthia L Miller; Joren C Madsen
Journal:  Curr Transplant Rep       Date:  2021-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.